Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Launch of pharmacogenetic test for clozapine-induced agranulocytosis

Jan. 25, 2007

NT-proBNP Test commercially launched in Europe

Jan. 25, 2007

Bayer Schering signs agreement for novel neurodegenerative imaging compounds

Jan. 23, 2007

Two phase I trials cleared to begin for Lymphoseek in prostate and colon cancers

Jan. 22, 2007

Sonazoid contrast agent launched in Japan

Jan. 11, 2007

Sequenom and Qiagen collaborate on prenatal diagnostics

Jan. 9, 2007

bioMerieux and ExonHit target prostate cancer in new screening program

Jan. 5, 2007

Combidex filed for approval in E.U.

Dec. 11, 2006

MPI studies with regadenoson comparable to MPI studies with Adenoscan

Dec. 5, 2006

Schering AG and Stanford University collaborate on molecular imaging

Nov. 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...